DE3612211A1
(de)
*
|
1986-04-11 |
1987-10-15 |
Basf Ag |
Kontinuierliches verfahren zum tablettieren
|
CA1334379C
(en)
*
|
1987-11-24 |
1995-02-14 |
James William Mcginity |
Method for preparing a solid sustained release form of a functionally active composition
|
US5051261A
(en)
*
|
1987-11-24 |
1991-09-24 |
Fmc Corporation |
Method for preparing a solid sustained release form of a functionally active composition
|
DE3803482A1
(de)
*
|
1988-02-05 |
1989-08-17 |
Lohmann Therapie Syst Lts |
Schwimmfaehiges orales therapeutisches system
|
DE3807895A1
(de)
*
|
1988-03-10 |
1989-09-21 |
Knoll Ag |
Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
|
DE3812567A1
(de)
*
|
1988-04-15 |
1989-10-26 |
Basf Ag |
Verfahren zur herstellung pharmazeutischer mischungen
|
DE3830355A1
(de)
*
|
1988-09-07 |
1990-03-15 |
Basf Ag |
Verfahren zur herstellung von pharmazeutischen tabletten
|
DE3830353A1
(de)
*
|
1988-09-07 |
1990-03-15 |
Basf Ag |
Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
|
PH26730A
(en)
*
|
1988-12-30 |
1992-09-28 |
Ciba Geigy Ag |
Coated adhesive tablets
|
US5310549A
(en)
*
|
1989-08-31 |
1994-05-10 |
Ecolab Inc. |
Solid concentrate iodine composition
|
WO1991007184A1
(en)
*
|
1989-11-08 |
1991-05-30 |
Gaf Chemicals Corporation |
SUBSTANTIALLY ANHYDROUS COMPLEXES OF PVP and H2O¿2?
|
US5008106A
(en)
*
|
1989-12-14 |
1991-04-16 |
Gaf Chemicals Corporation |
Method for reducing the microbial content of surfaces with a microbiocidal, anhydrous complex of PVP-H2 O2
|
IE63986B1
(en)
*
|
1989-12-30 |
1995-06-28 |
Akzo Nv |
Pharmaceutical preparation for oral administration in fluid form
|
FR2663818B1
(fr)
†
|
1990-06-29 |
1993-07-09 |
Rhone Poulenc Nutrition Animale |
Procede de preparation de granules de principes actifs par extrusion.
|
DE4031881C2
(de)
*
|
1990-10-08 |
1994-02-24 |
Sanol Arznei Schwarz Gmbh |
Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
|
CA2065603C
(en)
*
|
1991-04-09 |
2007-04-03 |
Hiroki Itoh |
Stabilized vitamin d preparation
|
AU1537292A
(en)
*
|
1991-04-16 |
1992-11-17 |
Nippon Shinyaku Co. Ltd. |
Method of manufacturing solid dispersion
|
US5286497A
(en)
*
|
1991-05-20 |
1994-02-15 |
Carderm Capital L.P. |
Diltiazem formulation
|
US5326570A
(en)
*
|
1991-07-23 |
1994-07-05 |
Pharmavene, Inc. |
Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
|
ES2120451T7
(es)
|
1991-09-06 |
2009-11-05 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Composicion que comprende un compuesto de tramadol y acetaminofeno, y su uso.
|
WO1993007859A1
(en)
*
|
1991-10-23 |
1993-04-29 |
Warner-Lambert Company |
Novel pharmaceutical pellets and process for their production
|
DE4138513A1
(de)
*
|
1991-11-23 |
1993-05-27 |
Basf Ag |
Feste pharmazeutische retardform
|
JP3722293B2
(ja)
|
1991-12-18 |
2005-11-30 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
新規な薬学的固体分散物
|
US5190749A
(en)
*
|
1992-01-13 |
1993-03-02 |
Isp Investments Inc. |
Copolymers of vinyl pyrrolidone and a quaternary ammonium monomer complexed with H2 O2 in the form of free-flowing powders
|
US5429825A
(en)
*
|
1992-06-26 |
1995-07-04 |
Mcneil-Ppc, Inc. |
Rotomelt granulation
|
TW246635B
(ro)
*
|
1992-10-08 |
1995-05-01 |
Shell Internat Res Schappej B V |
|
IL109460A
(en)
|
1993-05-10 |
1998-03-10 |
Euro Celtique Sa |
Controlled release formulation comprising tramadol
|
DE4316537A1
(de)
*
|
1993-05-18 |
1994-11-24 |
Basf Ag |
Zubereitungen in Form fester Lösungen
|
EP0729748B1
(en)
*
|
1993-11-18 |
2003-02-26 |
Nippon Shinyaku Company, Limited |
Process for producing stable medicinal composition
|
KR100354702B1
(ko)
*
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
US5843480A
(en)
*
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
DE4413350A1
(de)
|
1994-04-18 |
1995-10-19 |
Basf Ag |
Retard-Matrixpellets und Verfahren zu ihrer Herstellung
|
EP0691124A1
(en)
*
|
1994-07-07 |
1996-01-10 |
Sara Lee/DE N.V. |
Mouth care products
|
GB9422154D0
(en)
*
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
US20020006438A1
(en)
*
|
1998-09-25 |
2002-01-17 |
Benjamin Oshlack |
Sustained release hydromorphone formulations exhibiting bimodal characteristics
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
US5871776A
(en)
*
|
1995-01-31 |
1999-02-16 |
Mehta; Atul M. |
Controlled-release nifedipine
|
DE19504832A1
(de)
*
|
1995-02-14 |
1996-08-22 |
Basf Ag |
Feste Wirkstoff-Zubereitungen
|
DE19509806A1
(de)
*
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Lagerstabile Arzneiformen
|
DE19509805A1
(de)
*
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
|
DE19511131A1
(de)
*
|
1995-03-27 |
1996-10-02 |
Basf Ag |
Mechanisch stabile feste Wirkstoffzubereitungsformen
|
US5900425A
(en)
*
|
1995-05-02 |
1999-05-04 |
Bayer Aktiengesellschaft |
Pharmaceutical preparations having controlled release of active compound and processes for their preparation
|
BE1009375A6
(nl)
*
|
1995-05-29 |
1997-02-04 |
Picanol Nv |
Kanteninrichting voor weefmachines.
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
CA2231050A1
(en)
*
|
1995-09-07 |
1997-03-13 |
Biovail International Ltd. |
System for rendering substantially non-dissoluble bio-affecting agents bio-available
|
DE19539361A1
(de)
*
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
|
DE19602206A1
(de)
|
1996-01-23 |
1997-07-24 |
Basf Ag |
Zubereitungen nichtsteroidaler Analgetika
|
US6090419A
(en)
*
|
1996-05-02 |
2000-07-18 |
Mccormick & Company, Inc. |
Salt compositions and method of preparation
|
DE19629040A1
(de)
*
|
1996-07-19 |
1998-01-22 |
Basf Ag |
Pflanzenextrakthaltige Arzneiformen
|
DE19629753A1
(de)
*
|
1996-07-23 |
1998-01-29 |
Basf Ag |
Verfahren zur Herstellung von festen Arzneiformen
|
DE19635676A1
(de)
*
|
1996-09-03 |
1998-03-05 |
Basf Ag |
Feste geschäumte Wirkstoffzubereitungen
|
HRP970485A2
(en)
|
1996-09-13 |
1998-08-31 |
Joerg Rosenberg |
Process for producing solid pharmaceutical forms
|
DE19710213A1
(de)
*
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Verfahren zur Herstellung von festen Kombinationsarzneiformen
|
DE19753298A1
(de)
*
|
1997-12-01 |
1999-06-02 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
DE19812688A1
(de)
*
|
1998-03-23 |
1999-09-30 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
DE19814730A1
(de)
*
|
1998-04-02 |
1999-10-07 |
Basf Ag |
Verwendung von N-Vinyllacram oder N-Vinylamin haltigen Copolymeren als Matrix zur Herstellung von festen pharmazeutischen und kosmetischen Darreichungsformen
|
ES2221380T3
(es)
|
1998-04-30 |
2004-12-16 |
Basf Aktiengesellschaft |
Formulaciones retardadas de productos activos fitosanitarios.
|
US6197347B1
(en)
|
1998-06-29 |
2001-03-06 |
Andrx Pharmaceuticals, Inc. |
Oral dosage for the controlled release of analgesic
|
DE19840256A1
(de)
|
1998-09-03 |
2000-03-09 |
Basf Ag |
Verfahren zur Herstellung von beschichteten festen Dosierungsformen
|
DE19841244A1
(de)
|
1998-09-09 |
2000-03-16 |
Knoll Ag |
Verfahren und Vorrichtung zum Herstellen von Tabletten
|
DE19842914A1
(de)
|
1998-09-18 |
2000-03-23 |
Basf Ag |
Testsystem zur Charakterisierung der Verträglichkeit von biologisch aktiven Substanzen und Polyvinylpyrrolidon
|
DE19842753A1
(de)
|
1998-09-18 |
2000-03-23 |
Bayer Ag |
Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
|
DE19843904A1
(de)
|
1998-09-24 |
2000-03-30 |
Basf Ag |
Feste Dosierungsform mit polymerem Bindemittel
|
DE19843903A1
(de)
*
|
1998-09-24 |
2000-03-30 |
Basf Ag |
Feste Dosierungsform mit copolymerem Bindemittel
|
DE19847618A1
(de)
|
1998-10-15 |
2000-04-20 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
WO2000028816A1
(de)
*
|
1998-11-12 |
2000-05-25 |
Basf Aktiengesellschaft |
Pflanzenschutzmitteltabletten
|
DE19853985A1
(de)
*
|
1998-11-23 |
2000-05-25 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
UA73101C2
(en)
*
|
1998-12-16 |
2005-06-15 |
Aventic Pharmaceuticals Inc |
Antagonist of serotonin receptor encapsulated by biodegradable polymer and method for its manufacture
|
US6455526B1
(en)
|
1998-12-16 |
2002-09-24 |
Aventis Pharmaceuticals, Inc. |
Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
|
DE19901383A1
(de)
|
1999-01-15 |
2000-07-20 |
Knoll Ag |
Verfahren zur Herstellung unterschiedlicher fester Dosierungsformen
|
DE19913692A1
(de)
|
1999-03-25 |
2000-09-28 |
Basf Ag |
Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
DE19934610A1
(de)
*
|
1999-07-23 |
2001-01-25 |
Bayer Ag |
Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
|
DE19943501A1
(de)
|
1999-09-10 |
2001-03-15 |
Basf Ag |
Unterwassergranulation wirkstoffhaltiger Schmelzen
|
DE19945982A1
(de)
*
|
1999-09-24 |
2001-03-29 |
Knoll Ag |
Geschwindigkeitsbestimmte Partikel
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
WO2001034119A2
(en)
*
|
1999-11-12 |
2001-05-17 |
Abbott Laboratories |
Inhibitors of crystallization in a solid dispersion
|
US7364752B1
(en)
|
1999-11-12 |
2008-04-29 |
Abbott Laboratories |
Solid dispersion pharamaceutical formulations
|
US6544553B1
(en)
*
|
1999-12-28 |
2003-04-08 |
Watson Pharmaceuticals, Inc. |
Dosage forms and methods for oral delivery of progesterone
|
DE10017102A1
(de)
|
2000-04-06 |
2001-10-11 |
Basf Ag |
Verfahren zur Herstellung von festen Kreatin-Dosierungsformen und dadurch erhältliche Dosierungsformen
|
US6635277B2
(en)
|
2000-04-12 |
2003-10-21 |
Wockhardt Limited |
Composition for pulsatile delivery of diltiazem and process of manufacture
|
DE10026698A1
(de)
*
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
DE10029201A1
(de)
*
|
2000-06-19 |
2001-12-20 |
Basf Ag |
Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
US6500457B1
(en)
|
2000-08-14 |
2002-12-31 |
Peirce Management, Llc |
Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
|
DE10046541A1
(de)
*
|
2000-09-19 |
2002-03-28 |
Knoll Ag |
Mechanisch stabile darreichungsformen, enthaltend Ubichinone
|
ES2250504T3
(es)
|
2000-11-29 |
2006-04-16 |
Allergan Inc. |
Prevencion del rechazo de injerto en el ojo.
|
US20050175687A1
(en)
*
|
2001-01-30 |
2005-08-11 |
Mcallister Stephen M. |
Pharmaceutical formulations
|
GB0102342D0
(en)
|
2001-01-30 |
2001-03-14 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
US7883721B2
(en)
|
2001-01-30 |
2011-02-08 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
US7842308B2
(en)
|
2001-01-30 |
2010-11-30 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
GB0113841D0
(en)
*
|
2001-06-07 |
2001-08-01 |
Boots Co Plc |
Therapeutic agents
|
CA2471948A1
(en)
*
|
2002-01-03 |
2003-07-17 |
Smithkline Beecham Corporation |
Novel pharmaceutical dosage forms and method for producing same
|
AR038375A1
(es)
|
2002-02-01 |
2005-01-12 |
Pfizer Prod Inc |
Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
|
ES2309294T3
(es)
|
2002-02-01 |
2008-12-16 |
Pfizer Products Inc. |
Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferecncia de ester de colesterilo.
|
US8128957B1
(en)
*
|
2002-02-21 |
2012-03-06 |
Valeant International (Barbados) Srl |
Modified release compositions of at least one form of tramadol
|
US20050182056A9
(en)
*
|
2002-02-21 |
2005-08-18 |
Seth Pawan |
Modified release formulations of at least one form of tramadol
|
KR101173497B1
(ko)
*
|
2002-03-11 |
2012-08-14 |
알콘, 인코퍼레이티드 |
이식 가능한 약물 전달 시스템
|
DE10213242A1
(de)
*
|
2002-03-25 |
2003-10-16 |
Abbott Gmbh & Co Kg |
Testsystem zur Evaluierung der Kompatibilität biologisch aktiver Substanzen mit Copolymeren
|
ATE442130T1
(de)
|
2002-08-12 |
2009-09-15 |
Bend Res Inc |
Arzneizubereitungen bestehend aus arzneimitteln in halb-geordneter form und polymeren
|
US20050020613A1
(en)
*
|
2002-09-20 |
2005-01-27 |
Alpharma, Inc. |
Sustained release opioid formulations and method of use
|
DE10247037A1
(de)
*
|
2002-10-09 |
2004-04-22 |
Abbott Gmbh & Co. Kg |
Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
|
US20080051411A1
(en)
*
|
2002-12-17 |
2008-02-28 |
Cink Russell D |
Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
|
RU2356549C2
(ru)
*
|
2002-12-17 |
2009-05-27 |
Эббетт ГмбХ унд Ко.КГ |
Композиция, включающая фенофибриновую кислоту, ее физиологически приемлемую соль или производное
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
EP1592760A4
(en)
*
|
2003-01-31 |
2009-08-12 |
Smithkline Beecham Corp |
AS FIXED DISPERSIONS, COMPOSITIONS
|
BRPI0407181A
(pt)
*
|
2003-02-03 |
2006-02-07 |
Novartis Ag |
Formulação farmacêutica
|
US20050100608A1
(en)
*
|
2003-02-21 |
2005-05-12 |
Watson Pharmaceuticals, Inc. |
Testosterone oral dosage formulations and associated methods
|
US20040219210A1
(en)
*
|
2003-05-01 |
2004-11-04 |
Jian-Hwa Guo |
Controlled release solid dosage nifedipine formulations
|
WO2005003192A1
(en)
*
|
2003-06-26 |
2005-01-13 |
Symyx Technologies, Inc. |
Synthesis of photoresist polymers
|
TW200526274A
(en)
|
2003-07-21 |
2005-08-16 |
Smithkline Beecham Plc |
Pharmaceutical formulations
|
US8025899B2
(en)
*
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
US8377952B2
(en)
*
|
2003-08-28 |
2013-02-19 |
Abbott Laboratories |
Solid pharmaceutical dosage formulation
|
US20050152855A1
(en)
*
|
2003-09-19 |
2005-07-14 |
Damian Hajduk |
Materials for enhanced delivery of hydrophilic active agents in personal care formulations
|
MXPA06005545A
(es)
*
|
2003-11-18 |
2006-08-17 |
Boehringer Ingelheim Int |
Preparacion farmaceutica solida.
|
GB0403098D0
(en)
*
|
2004-02-12 |
2004-03-17 |
Euro Celtique Sa |
Extrusion
|
TWI350762B
(en)
*
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
TW201240679A
(en)
*
|
2004-03-12 |
2012-10-16 |
Capsugel Belgium Nv |
Pharmaceutical formulations
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US20070237823A1
(en)
*
|
2004-05-04 |
2007-10-11 |
Thomas Bock |
Solid Pharmaceutical Form Comprising and Ltb4 Antagonist
|
DK1748762T3
(en)
|
2004-05-28 |
2014-03-17 |
Abbvie Deutschland |
Dosage form which can be obtained from a powder mixture comprising an inorganic pigment
|
FR2875409B1
(fr)
*
|
2004-09-17 |
2010-05-07 |
Sanofi Aventis |
Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose
|
KR20080007358A
(ko)
*
|
2005-05-10 |
2008-01-18 |
노파르티스 아게 |
변형 방출형 팜시클로비르 제약 조성물
|
WO2007002597A2
(en)
|
2005-06-27 |
2007-01-04 |
Biovail Laboratories International S.R.L. |
Modified-release formulations of a bupropion salt
|
CN101217981A
(zh)
*
|
2005-07-05 |
2008-07-09 |
阿伯特有限及两合公司 |
包含固体或半固体基质的组合物和剂型
|
ES2571032T3
(es)
|
2005-08-08 |
2016-05-23 |
Abbvie Deutschland |
Composiciones de itraconazol con biodisponibilidad mejorada
|
PT1912626T
(pt)
|
2005-08-08 |
2016-07-20 |
Abbvie Deutschland |
Formas farmacêuticas com biodisponibilidade melhorada
|
US7534381B2
(en)
*
|
2005-09-14 |
2009-05-19 |
Isp Investments Inc. |
Process and apparatus for forming agglomerates of a powder composition of an active and binder
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
EP1832281A1
(en)
*
|
2006-03-10 |
2007-09-12 |
Abbott GmbH & Co. KG |
Process for producing a solid dispersion of an active ingredient
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20080057122A1
(en)
*
|
2006-08-31 |
2008-03-06 |
Aaipharma Inc. |
Acetaminophen pharmaceutical compositions
|
WO2008067164A2
(en)
*
|
2006-11-15 |
2008-06-05 |
Abbott Laboratories |
Solid pharmaceutical dosage formulations
|
US20080145405A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Kunzler Jay F |
Drug delivery devices
|
US7607596B1
(en)
|
2007-03-07 |
2009-10-27 |
Exxpharma, LLC |
Process for enhancing the solubility of poorly soluble drugs
|
JP2011503048A
(ja)
|
2007-11-08 |
2011-01-27 |
グラクソ グループ リミテッド |
医薬製剤
|
US20090246276A1
(en)
|
2008-01-28 |
2009-10-01 |
Graham Jackson |
Pharmaceutical Compositions
|
AU2009256572A1
(en)
*
|
2008-06-13 |
2009-12-17 |
Capsugel Belgium Nv |
Hydroxypropyl cellulose capsule shell
|
US20100003322A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Lai Felix S |
Enteric coated hydrophobic matrix formulation
|
WO2010040686A1
(de)
*
|
2008-10-07 |
2010-04-15 |
Basf Se |
Verfahren zur herstellung oraler darreichungsformen mit kontrollierter freisetzung
|
HUE030800T2
(en)
|
2008-10-07 |
2017-05-29 |
Astrazeneca Uk Ltd |
Pharmaceutical Form No. 514
|
CN102573755A
(zh)
*
|
2009-09-18 |
2012-07-11 |
巴斯夫欧洲公司 |
制备具有低水溶性的物质的制剂的方法
|
EP2536393B1
(en)
|
2010-02-18 |
2014-04-16 |
AbbVie Deutschland GmbH & Co KG |
Test solvent for evaluating the compatibility of biologically active substances and graft copolymers
|
EP2463327A3
(de)
|
2010-12-10 |
2015-06-03 |
Basf Se |
Verfahren zur herstellung von granulaten, enthaltend mindestens eine wasserlösliche komponente
|
SG191316A1
(en)
|
2010-12-23 |
2013-07-31 |
Abbott Gmbh & Co Kg |
Solid retard formulations based on solid dispersions
|
JP6491669B2
(ja)
|
2014-02-05 |
2019-03-27 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
Cgrp活性化合物の錠剤製剤
|
CN104666084B
(zh)
*
|
2014-11-27 |
2018-07-13 |
天津坤健生物制药有限公司 |
一种提高缓控释包衣片溶出度稳定性的方法
|
MD4399C1
(ro)
*
|
2015-02-19 |
2016-09-30 |
Государственный Университет Молд0 |
Material polimeric cu proprietăţi antibacteriene
|
WO2018064181A1
(en)
|
2016-09-27 |
2018-04-05 |
Porter Kenneth L |
Harvested bale wrapping material sheets
|
WO2019087084A1
(en)
|
2017-11-02 |
2019-05-09 |
Eman Biodiscoveries Sd. Bhd. |
Extract of orthosiphon stamineus, formulations, and uses thereof
|